These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17086174)

  • 21. RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage.
    Fu X; Yucer N; Liu S; Li M; Yi P; Mu JJ; Yang T; Chu J; Jung SY; O'Malley BW; Gu W; Qin J; Wang Y
    Proc Natl Acad Sci U S A; 2010 Mar; 107(10):4579-84. PubMed ID: 20173098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. USP11 regulates p53 stability by deubiquitinating p53.
    Ke JY; Dai CJ; Wu WL; Gao JH; Xia AJ; Liu GP; Lv KS; Wu CL
    J Zhejiang Univ Sci B; 2014 Dec; 15(12):1032-8. PubMed ID: 25471832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRIAD1 is negatively regulated by the MDM2 E3 ligase.
    Bae S; Jung JH; An IS; Kim OY; Lee MJ; Lee JH; Park IC; Lee SJ; An S
    Oncol Rep; 2012 Nov; 28(5):1924-8. PubMed ID: 22940738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The MDM2-p53 interaction.
    Moll UM; Petrenko O
    Mol Cancer Res; 2003 Dec; 1(14):1001-8. PubMed ID: 14707283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual-site regulation of MDM2 E3-ubiquitin ligase activity.
    Wallace M; Worrall E; Pettersson S; Hupp TR; Ball KL
    Mol Cell; 2006 Jul; 23(2):251-63. PubMed ID: 16857591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation.
    Jin Y; Lee H; Zeng SX; Dai MS; Lu H
    EMBO J; 2003 Dec; 22(23):6365-77. PubMed ID: 14633995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity.
    Stindt MH; Carter S; Vigneron AM; Ryan KM; Vousden KH
    Cell Cycle; 2011 Sep; 10(18):3176-88. PubMed ID: 21900752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The p53 response to DNA damage.
    Meek DW
    DNA Repair (Amst); 2004; 3(8-9):1049-56. PubMed ID: 15279792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of p53 stability by Mdm2.
    Kubbutat MH; Jones SN; Vousden KH
    Nature; 1997 May; 387(6630):299-303. PubMed ID: 9153396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells.
    Duan W; Gao L; Wu X; Zhang Y; Otterson GA; Villalona-Calero MA
    Exp Cell Res; 2006 Oct; 312(17):3370-8. PubMed ID: 16934800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of p53 and MDM2 activity by MTBP.
    Brady M; Vlatkovic N; Boyd MT
    Mol Cell Biol; 2005 Jan; 25(2):545-53. PubMed ID: 15632057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
    Honda R; Yasuda H
    EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small molecules that bind the Mdm2 RING stabilize and activate p53.
    Roxburgh P; Hock AK; Dickens MP; Mezna M; Fischer PM; Vousden KH
    Carcinogenesis; 2012 Apr; 33(4):791-8. PubMed ID: 22301280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo.
    Xirodimas D; Saville MK; Edling C; Lane DP; Laín S
    Oncogene; 2001 Aug; 20(36):4972-83. PubMed ID: 11526482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A high-throughput screen measuring ubiquitination of p53 by human mdm2.
    Murray MF; Jurewicz AJ; Martin JD; Ho TF; Zhang H; Johanson KO; Kirkpatrick RB; Ma J; Lor LA; Thrall SH; Schwartz B
    J Biomol Screen; 2007 Dec; 12(8):1050-8. PubMed ID: 17989425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
    Moumen A; Masterson P; O'Connor MJ; Jackson SP
    Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53-independent induction of rat hepatic Mdm2 following administration of phenobarbital and pregnenolone 16alpha-carbonitrile.
    Nelson DM; Bhaskaran V; Foster WR; Lehman-McKeeman LD
    Toxicol Sci; 2006 Dec; 94(2):272-80. PubMed ID: 17000718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L2DTL/CDT2 and PCNA interact with p53 and regulate p53 polyubiquitination and protein stability through MDM2 and CUL4A/DDB1 complexes.
    Banks D; Wu M; Higa LA; Gavrilova N; Quan J; Ye T; Kobayashi R; Sun H; Zhang H
    Cell Cycle; 2006 Aug; 5(15):1719-29. PubMed ID: 16861890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Competitive ubiquitination activates the tumor suppressor p53.
    Li X; Guo M; Cai L; Du T; Liu Y; Ding HF; Wang H; Zhang J; Chen X; Yan C
    Cell Death Differ; 2020 Jun; 27(6):1807-1818. PubMed ID: 31796886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9.
    Buschmann T; Lerner D; Lee CG; Ronai Z
    J Biol Chem; 2001 Nov; 276(44):40389-95. PubMed ID: 11384992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.